MITF and neoplasm: In addition, a few resistant tumours do not restore ERK phosphorylation [49,54,62,63] but seem to bypass the MAPK pathway through the activation of a more downstream oncogenic output through GPCR-cAMP-CREB signalling and amplification of MITF [64].